Privia Health Gr Analyst Price Targets

Wall Street analyst price targets and consensus rating for Privia Health Gr (PRVA).

Price Target Range — 11 Quarters

Analyst Consensus — 20 Analysts

3S.Buy

16Buy

1Hold

Consensus RatingOutperform# Analysts20Avg. Consensus PT$29Upside to Avg. PT+30.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 26, 2026	Barclays	Andrew Mok	PT Cut	Equal-Weight	$25→$24
May 8, 2026	Canaccord Genuity	Richard Close	PT Cut	Buy	$35→$34
Apr 8, 2026	Evercore ISI Group	Elizabeth Anderson	PT Cut	Outperform	$30→$26
Mar 25, 2026	Barclays	Andrew Mok	PT Raise	Equal-Weight	$23→$25
Mar 3, 2026	Citigroup	Daniel Grosslight	PT Cut	Buy	$34→$32
Mar 2, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$31→$33
Feb 27, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$34→$35
Jan 9, 2026	RBC Capital	Ryan Halsted	Reinstates	Outperform	$31
Dec 4, 2025	Stephens & Co.	Jeff Garro	Maintained	Overweight	$32
Nov 13, 2025	JP Morgan	Lisa Gill	PT Raise	Overweight	$32→$33
Nov 13, 2025	BMO Capital	Sean Dodge	Initiate	Outperform	$30
Nov 12, 2025	Canaccord Genuity	Richard Close	PT Raise	Buy	$32→$34
Nov 10, 2025	Barclays	Andrew Mok	PT Raise	Equal-Weight	$22→$23
Nov 10, 2025	Truist Securities	Jailendra Singh	PT Raise	Buy	$30→$31
Nov 7, 2025	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$28→$30
Nov 7, 2025	Citizens	Constantine Davides	PT Raise	Market Outperform	$30→$31
Oct 9, 2025	Barclays	Andrew Mok	PT Raise	Equal-Weight	$21→$22
Sep 24, 2025	Stephens & Co.	Jeff Garro	Maintained	Overweight	$32
Sep 4, 2025	Stephens & Co.	Jeff Garro	Maintained	Overweight	$32
Aug 29, 2025	JMP Securities	David M. Scharf	PT Raise	Market Outperform	$29→$30

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $35 to $34.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $26

Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the price target from $30 to $26.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $25

Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and raises the price target from $23 to $25.

Benzinga Newsdesk

Breaking Down Privia Health Gr: 5 Analysts Share Their Views

Benzinga Insights

PRO
Citigroup Maintains Buy on Privia Health Gr, Lowers Price Target to $32

Citigroup analyst Daniel Grosslight maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $34 to $32.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $33

Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $31 to $33.

Benzinga Newsdesk

Privia Health Group Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Privia Health Gr Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34

PRO
Evercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $26

PRO
Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $25

Breaking Down Privia Health Gr: 5 Analysts Share Their Views

PRO
Citigroup Maintains Buy on Privia Health Gr, Lowers Price Target to $32

PRO
Truist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $33

People Also Watch

People Also Watch

Privia Health Group Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Privia Health Gr Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCanaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34

PROEvercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $26

PROBarclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $25

Breaking Down Privia Health Gr: 5 Analysts Share Their Views

PROCitigroup Maintains Buy on Privia Health Gr, Lowers Price Target to $32

PROTruist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $33

People Also Watch

People Also Watch

PRO
Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34

PRO
Evercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $26

PRO
Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $25

PRO
Citigroup Maintains Buy on Privia Health Gr, Lowers Price Target to $32

PRO
Truist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $33